US OptionsDetailed Quotes

FWRG250117C22500

Watchlist

0.05
0.000.00%

15min DelayClose Jan 17 16:00 ET

0.00High0.00Low

First Watch Restaurant Stock Discussion

Jaguar8

Apr 15, 2024 15:32

$First Watch Restaurant (FWRG.US)$
NEWS
First Watch Acquires 21 Franchise Restaurants in North Carolina

Moomoo AI

Mar 8, 2024 13:21

Optimism grows on First Watch Restaurant Group's earnings potential following recent results. The consensus earnings per share upgrade indicates a clear improvement in sentiment around the company's earnings potential next year.

US$27.89 - That's What Analysts Think First Watch Restaurant Group, Inc. (NASDAQ:FWRG) Is Worth After These Results

Moomoo AI

Jan 23, 2024 04:44

Despite First Watch Restaurant Group's strong revenue outlook, the market isn't reflecting this in its P/S ratio, possibly due to perceived risks. If investors align with analysts' forecasts, the stock may be seen as attractively priced.

First Watch Restaurant Group, Inc.'s (NASDAQ:FWRG) Subdued P/S Might Signal An Opportunity

Moomoo AI

Jan 7, 2024 08:28

The increasing returns on a growing amount of capital are impressive. Given the promising fundamentals, the company seems to be a candidate for further due diligence.

Investors Will Want First Watch Restaurant Group's (NASDAQ:FWRG) Growth In ROCE To Persist

Phant0m

Aug 10, 2023 10:13

Watch out this stocks

$Cheetah Net Supply Chain Service (CTNT.US)$ $Anixa Biosciences (ANIX.US)$ $First Watch Restaurant (FWRG.US)$

Moomoo Breakfast US

Sep 13, 2022 07:42

Columns Today's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More

Gapping up
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...

No comment yet